Virtu Financial’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-128,231
| Closed | -$21K | – | 2225 |
|
|
2024
Q4 | $21K | Buy |
+128,231
| New | +$21K | ﹤0.01% | 1296 |
|
|
2024
Q3 | – | Sell |
-30,789
| Closed | -$17K | – | 2012 |
|
|
2024
Q2 | $17K | Buy |
+30,789
| New | +$17K | ﹤0.01% | 1057 |
|
|
2024
Q1 | – | Sell |
-27,378
| Closed | -$16K | – | 2254 |
|
|
2023
Q4 | $16K | Buy |
+27,378
| New | +$16K | ﹤0.01% | 1356 |
|
|
2023
Q1 | – | Sell |
-19,568
| Closed | -$29K | – | 2221 |
|
|
2022
Q4 | $29K | Buy |
+19,568
| New | +$29K | ﹤0.01% | 1191 |
|
|
2020
Q3 | – | Sell |
-2,533
| Closed | -$23K | – | 1619 |
|
|
2020
Q2 | $23K | Buy |
+2,533
| New | +$23K | ﹤0.01% | 1122 |
|
|
2019
Q4 | – | Sell |
-1,036
| Closed | -$26K | – | 1936 |
|
|
2019
Q3 | $26K | Buy |
1,036
+374
| +56% | +$9.39K | ﹤0.01% | 1265 |
|
|
2019
Q2 | $17K | Buy |
+662
| New | +$17K | ﹤0.01% | 1344 |
|
|
2018
Q2 | – | Sell |
-1,060
| Closed | -$101K | – | 2591 |
|
|
2018
Q1 | $101K | Buy |
+1,060
| New | +$101K | 0.01% | 1574 |
|
|
2017
Q4 | – | Sell |
-288
| Closed | -$20K | – | 3127 |
|
|
2017
Q3 | $20K | Buy |
+288
| New | +$20K | ﹤0.01% | 2353 |
|